Korea University Guro Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Employees: -

Market Cap: -

Website: http://guro.kumc.or.kr

Clinical Trials

Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance

Phase 2

Recruiting

Conditions: Ovarian Cancer
Drug Related Neoplasm/Cancer

Interventions: Procedure: secondary cytoreductive surgery
Drug: chemotherapy

First Posted Date: 2023-01-30

Last Posted Date: 2024-03-12

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 124

Registration Number: NCT05704621

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Republic of

Impact of Flumazenil on the Emergence Delirium

Phase 4

Completed

Conditions: Anesthesia, General

Interventions: Drug: Flumazenil

First Posted Date: 2023-01-12

Last Posted Date: 2023-09-06

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 68

Registration Number: NCT05681377

Locations: 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of

Two-channel IV-PCA With Dexmedetomidine

Not Applicable

Recruiting

Conditions: Analgesia, Patient-Controlled
Dexmedetomidine

Interventions: Drug: Control
Drug: Dexmedetomidine

First Posted Date: 2023-01-05

Last Posted Date: 2025-01-03

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 110

Registration Number: NCT05672225

Locations: 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of

Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood

Recruiting

Conditions: Lung Cancer
Diagnosis

First Posted Date: 2022-10-19

Last Posted Date: 2022-10-19

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 150

Registration Number: NCT05587114

Locations: 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of

Effect of Remimazolam on Motor Evoked Potential

Not Applicable

Completed

Conditions: Spine Disease

Interventions: Drug: Propofol
Drug: Remimazolam Besylate

First Posted Date: 2022-07-12

Last Posted Date: 2023-03-15

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 20

Registration Number: NCT05453955

Locations: 🇰🇷
Seok Kyeong Oh, Seoul, Gangnam-gu, Korea, Republic of

Deep Neuromuscular Block on Postoperative Delirium in Lumbar Surgery

Not Applicable

Completed

Conditions: Lumbar Spine Disease

Interventions: Drug: Rocuronium for moderate NMB
Drug: Rocuronium for deep NMB

First Posted Date: 2022-07-12

Last Posted Date: 2025-01-03

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 230

Registration Number: NCT05453929

Locations: 🇰🇷
Seok Kyeong Oh, Seoul, Gangnam-gu, Korea, Republic of

Anesthesia Induction With Intravenous Bolus or Continuous Infusion of Remimazolam

Phase 4

Completed

Conditions: Anesthesia, General
Adult

Interventions: Drug: Infusion of remimazolam
Drug: Bolus injection of remimazolam

First Posted Date: 2022-06-21

Last Posted Date: 2022-12-09

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 100

Registration Number: NCT05423080

Locations: 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of

Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms

Conditions: Vaccine Adverse Reaction
Inflammation
Vaccine Immune Response
COVID-19 Vaccination

Interventions: Biological: either BNT162b2 or ChAdOx1 vaccine

First Posted Date: 2022-04-07

Last Posted Date: 2022-04-07

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 120

Registration Number: NCT05315856

Locations: 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
🇰🇷
Ajou University School of Medicine, Suwon, Gyeonggi-do, Korea, Republic of
🇰🇷
Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of

Alleviating Stress by Mobile Application' for Depression

Not Applicable

Recruiting

Conditions: Major Depressive Disorder

Interventions: Other: the App

First Posted Date: 2022-04-05

Last Posted Date: 2023-11-02

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 42

Registration Number: NCT05312203

Locations: 🇰🇷
Department of Psychiatry, Korea University Guro Hospital, Seoul, Guro Gu, Korea, Republic of

Intravenous Iron Infusion on Chemotherapy-induced Anemia

Phase 2

Not yet recruiting

Conditions: Colon Cancer
Chemotherapeutic-Induced Anemia

Interventions: Drug: iron (isomaltoside)
Drug: Dried Ferrous Sulfate

First Posted Date: 2022-03-29

Last Posted Date: 2022-03-29

Lead Sponsor: Korea University Guro Hospital

Target Recruit Count: 80

Registration Number: NCT05299411

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy